High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9) , 1391-1397
- https://doi.org/10.1016/0277-5379(87)90125-8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.Journal of Clinical Oncology, 1986
- High dose cisplatin and high dose carboplatin in refractory ovarian cancerCancer Treatment Reviews, 1985
- Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancerCancer Treatment Reviews, 1985
- Results of NCI-sponsored phase I trials with carboplatinCancer Treatment Reviews, 1985
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Alterations in the toxicity of cis-Dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administrationToxicology and Applied Pharmacology, 1981
- Reporting results of cancer treatmentCancer, 1981
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977